BioCentury | Aug 18, 2016
Distillery Therapeutics

Therapeutics: c-jun N-terminal kinase (JNK); JNK1 (MAPK8)

...for dry eye. Opko Health Inc. and The Scripps Research Institute have the JNK inhibitor SR-3306...
BioCentury | Jan 7, 2016
Distillery Therapeutics

Therapeutics: c-jun N-terminal kinase (JNK); caspase recruitment domain family member 11 (CARD11)

...treat dry eye. Opko Health Inc. and The Scripps Research Institute have the JNK inhibitor SR-3306...
BioCentury | Feb 27, 2014
Distillery Techniques

Technology: Markers

...to treat stroke. Opko Health Inc. and The Scripps Research Institute have the JNK inhibitor SR-3306...
BioCentury | Mar 19, 2012
Company News

Opko, Scripps Research Institute deal

...The institute granted Opko exclusive, worldwide rights to develop and commercialize SR-3306 . The c-jun N-terminal...
Items per page:
1 - 4 of 4